Harrow Announces Participation in Upcoming Investor Conferences

Business Wire

2024-11-15

NASHVILLE, Tenn., November 15, 2024--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that management will participate in the following three investor conferences:

Craig-Hallum 15^th Annual Alpha Select Conference (Sheraton New York Times Square Hotel)
November 19, 2024
1x1 Meetings Only

BTIG 4^th Annual Ophthalmology Day (Virtual)
December 2, 2024
1x1 Virtual Meetings Only

Piper Sandler 36^th Annual Healthcare Conference (The Lotte New York Palace)
December 3-5, 2024
Company will host a Fireside Chat at 8:00 a.m. ET on December 4, 2024

The Company will conduct one-on-one meetings at each conference. Investors interested in meeting with management during conferences should contact their representative at each firm to request a meeting. Only the Piper Sandler conference will include an audio webcast, which will be available on the Company’s website.

About Harrow
Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market. Harrow helps eyecare professionals preserve the gift of sight by making its portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of patients each year. For more information about Harrow, please visit harrow.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241115031085/en/

Contacts

Jamie Webb, Director of Communications and Investor Relations
jwebb@harrowinc.com
615-733-4737

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2483327166"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2483327166\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2483327166?lang=zh_TW&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/rbkSzK_l3CDTPen2XWR_jA--~B/aD0yNTI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/c4e685a07f86e65bee45c999dd6ee1c1","is_english":true,"pubTime":"2024-11-15 20:00","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2483327166","market":"us","top_or_hot":-1,"title":"Harrow Announces Participation in Upcoming Investor Conferences","media":"Business Wire","content":"<html><body>\n<figure>\n<img border=\"0\" height=\"252\" src=\"https://s1.yimg.com/uu/api/res/1.2/BpfrJkryaDWCuyulBWDB0A--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/business-wire.com/c4e685a07f86e65bee45c999dd6ee1c1\" title=\"\" width=\"480\"/>\n<figcaption></figcaption>\n</figure>\n<p><b>NASHVILLE, Tenn., November 15, 2024</b>--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that management will participate in the following three investor conferences:</p>\n<p><b><i>Craig-Hallum 15<sup>th</sup> Annual Alpha Select Conference (Sheraton New York Times Square Hotel)<br/></i></b><i>November 19, 2024<br/></i><i>1x1 Meetings Only</i></p>\n<p><b><i>BTIG 4<sup>th</sup> Annual Ophthalmology Day (Virtual)<br/></i></b><i>December 2, 2024<br/></i><i>1x1 Virtual Meetings Only</i></p>\n<p><b><i>Piper Sandler 36<sup>th</sup> Annual Healthcare Conference (The Lotte New York Palace)<br/></i></b><i>December 3-5, 2024<br/></i><i>Company will host a Fireside Chat at 8:00 a.m. ET on December 4, 2024</i></p>\n<p>The Company will conduct one-on-one meetings at each conference. Investors interested in meeting with management during conferences should contact their representative at each firm to request a meeting. Only the Piper Sandler conference will include an audio webcast, which will be available on the Company’s website.</p>\n<p><b>About Harrow<br/></b>Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market. Harrow helps eyecare professionals preserve the gift of sight by making its portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of patients each year. For more information about Harrow, please visit harrow.com.</p>\n<p><span>View source version on businesswire.com: </span><span>https://www.businesswire.com/news/home/20241115031085/en/</span></p>\n<p><b>Contacts</b></p>\n<p>Jamie Webb, Director of Communications and Investor Relations<br/>jwebb@harrowinc.com <br/>615-733-4737<br/><br/></p></body></html>","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Harrow Announces Participation in Upcoming Investor Conferences</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHarrow Announces Participation in Upcoming Investor Conferences\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Business Wire</strong><span class=\"h-time small\">2024-11-15 20:00</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body>\n<figure>\n<img border=\"0\" height=\"252\" src=\"https://s1.yimg.com/uu/api/res/1.2/BpfrJkryaDWCuyulBWDB0A--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/business-wire.com/c4e685a07f86e65bee45c999dd6ee1c1\" title=\"\" width=\"480\"/>\n<figcaption></figcaption>\n</figure>\n<p><b>NASHVILLE, Tenn., November 15, 2024</b>--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that management will participate in the following three investor conferences:</p>\n<p><b><i>Craig-Hallum 15<sup>th</sup> Annual Alpha Select Conference (Sheraton New York Times Square Hotel)<br/></i></b><i>November 19, 2024<br/></i><i>1x1 Meetings Only</i></p>\n<p><b><i>BTIG 4<sup>th</sup> Annual Ophthalmology Day (Virtual)<br/></i></b><i>December 2, 2024<br/></i><i>1x1 Virtual Meetings Only</i></p>\n<p><b><i>Piper Sandler 36<sup>th</sup> Annual Healthcare Conference (The Lotte New York Palace)<br/></i></b><i>December 3-5, 2024<br/></i><i>Company will host a Fireside Chat at 8:00 a.m. ET on December 4, 2024</i></p>\n<p>The Company will conduct one-on-one meetings at each conference. Investors interested in meeting with management during conferences should contact their representative at each firm to request a meeting. Only the Piper Sandler conference will include an audio webcast, which will be available on the Company’s website.</p>\n<p><b>About Harrow<br/></b>Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market. Harrow helps eyecare professionals preserve the gift of sight by making its portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of patients each year. For more information about Harrow, please visit harrow.com.</p>\n<p><span>View source version on businesswire.com: </span><span>https://www.businesswire.com/news/home/20241115031085/en/</span></p>\n<p><b>Contacts</b></p>\n<p>Jamie Webb, Director of Communications and Investor Relations<br/>jwebb@harrowinc.com <br/>615-733-4737<br/><br/></p></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://finance.yahoo.com/news/harrow-announces-participation-upcoming-investor-120000137.html\">Business Wire</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"製藥","start_time":0,"source_url":"https://finance.yahoo.com/news/harrow-announces-participation-upcoming-investor-120000137.html","article_id":"2483327166","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/rbkSzK_l3CDTPen2XWR_jA--~B/aD0yNTI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/c4e685a07f86e65bee45c999dd6ee1c1"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483327166","pubTimestamp":1731672000,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"NASHVILLE, Tenn., November 15, 2024----Harrow , a leading North American eyecare pharmaceutical company, today announced that management will participate in the following three investor conferences:. Craig-Hallum 15th Annual Alpha Select Conference November 19, 20241x1 Meetings Only. BTIG 4th Annual Ophthalmology Day December 2, 20241x1 Virtual Meetings Only. Piper Sandler 36th Annual Healthcare Conference December 3-5, 2024Company will host a Fireside Chat at 8:00 a.m. ET on December 4, 2024. The Company will conduct one-on-one meetings at each conference. Investors interested in meeting with management during conferences should contact their representative at each firm to request a meeting. Only the Piper Sandler conference will include an audio webcast, which will be available on the Company’s website.About HarrowHarrow, Inc.  is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for ","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","HROW":"Harrow Health Inc","BK4557":"大麻股"},"translate_title":"哈罗宣布参加即将举行的投资者会议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HROW":0.9},"content_text":"NASHVILLE, Tenn., November 15, 2024--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that management will participate in the following three investor conferences:\nCraig-Hallum 15th Annual Alpha Select Conference (Sheraton New York Times Square Hotel)November 19, 20241x1 Meetings Only\nBTIG 4th Annual Ophthalmology Day (Virtual)December 2, 20241x1 Virtual Meetings Only\nPiper Sandler 36th Annual Healthcare Conference (The Lotte New York Palace)December 3-5, 2024Company will host a Fireside Chat at 8:00 a.m. ET on December 4, 2024\nThe Company will conduct one-on-one meetings at each conference. Investors interested in meeting with management during conferences should contact their representative at each firm to request a meeting. Only the Piper Sandler conference will include an audio webcast, which will be available on the Company’s website.\nAbout HarrowHarrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market. Harrow helps eyecare professionals preserve the gift of sight by making its portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of patients each year. For more information about Harrow, please visit harrow.com.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20241115031085/en/\nContacts\nJamie Webb, Director of Communications and Investor Relationsjwebb@harrowinc.com 615-733-4737","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"conferences","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}